Senoo Haruki
Department of Anatomy, Akita University School of Medicine, 1-1-1 Hondo, 010-8543, Akita, Japan.
Med Electron Microsc. 2004 Mar;37(1):3-15. doi: 10.1007/s00795-003-0230-3.
Hepatic stellate cells (vitamin A-storing cells, lipocytes, interstitial cells, fat-storing cells, Ito cells) exist in the space between parenchymal cells and sinusoidal endothelial cells of the hepatic lobule and store 80% of retinoids in the whole body as retinyl palmitate in lipid droplets in the cytoplasm. In physiological conditions, these cells play pivotal roles in the regulation of retinoid homeostasis; they express specific receptors for retinol-binding protein (RBP), a binding protein specific for retinol, on their cell surface, and take up the complex of retinol and RBP by receptor-mediated endocytosis. Hepatic stellate cells in arctic animals such as polar bears and arctic foxes store 20-100 times the levels of retinoids found in humans or rats. In pathological conditions such as liver fibrosis, hepatic stellate cells lose retinoids, and synthesize a large amount of extracellular matrix (ECM) components including collagen, proteoglycan, and adhesive glycoproteins. Morphology of these cells also changes from the star-shaped stellate cells to that of fibroblasts or myofibroblasts. The three-dimensional structure of ECM components was found to regulate reversibly the morphology, proliferation, and functions of the hepatic stellate cells. Molecular mechanisms in the reversible regulation of the stellate cells by ECM imply cell-surface integrin binding to ECM components, followed by signal transduction processes and then cytoskeleton assembly. Stellate cells also exist in extrahepatic organs such as pancreas, lung, kidney, and intestine. Hepatic and extrahepatic stellate cells form the stellate cell system.
肝星状细胞(维生素A储存细胞、脂肪细胞、间质细胞、贮脂细胞、伊托细胞)存在于肝小叶实质细胞和窦状内皮细胞之间的间隙中,以细胞质中脂滴内的视黄醇棕榈酸酯形式储存全身80%的类视黄醇。在生理条件下,这些细胞在类视黄醇稳态调节中起关键作用;它们在细胞表面表达视黄醇结合蛋白(RBP,一种视黄醇特异性结合蛋白)的特异性受体,并通过受体介导的内吞作用摄取视黄醇和RBP的复合物。北极熊和北极狐等北极动物的肝星状细胞储存的类视黄醇水平是人类或大鼠的20 - 100倍。在肝纤维化等病理条件下,肝星状细胞失去类视黄醇,并合成大量细胞外基质(ECM)成分,包括胶原蛋白、蛋白聚糖和黏附糖蛋白。这些细胞的形态也从星形星状细胞转变为成纤维细胞或肌成纤维细胞。发现ECM成分的三维结构可可逆地调节肝星状细胞的形态、增殖和功能。ECM对星状细胞可逆调节的分子机制意味着细胞表面整合素与ECM成分结合,随后是信号转导过程,然后是细胞骨架组装。星状细胞也存在于胰腺、肺、肾和肠道等肝外器官中。肝内和肝外星状细胞形成星状细胞系统。